The global liquid biopsy market is projected to reach $19.06 billion in terms of revenue by 2032 at a CAGR of 19.83%, reveals the premium market intelligence study by BIS Research. The premium market intelligence by BIS Research additionally throws a spotlight on the opportunities existing in the market, including the high scope for adoption of sequencing in emerging...